Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.


We screened the antiischemic, hemodynamic, and inotropic effects of different dosages of the new calcium channel blocker Ro 40-5967 in 65 patients with stable effort-induced angina pectoris. In a double-blind way, patients were randomized to recieve a single oral dose of 50, 100, or 200 mg Ro 40-5967 or placebo, given as a drinking solution. Left… (More)


  • Presentations referencing similar topics